US OptionsDetailed Quotes
MRK241122P107000
- 10.50
- 0.000.00%
15min DelayClose Nov 22 16:00 ET
0.00High0.00Low
10.50Open10.50Pre Close0 Volume2 Open Interest107.00Strike Price0.00Turnover0.00%IV2.70%PremiumNov 22, 2024Expiry Date7.82Intrinsic Value100Multiplier-1DDays to Expiry2.68Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma12.92Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Merck & Co Stock Discussion
Sign in to post a comment
$Merck & Co (MRK.US)$ $Incyte (INCY.US)$ is a great company. Buying it would be a good decision, unless Merck massively overpays.
2
$Merck & Co (MRK.US)$ how do drugs go up and down like this? theyre drugs, they pretty much sell themselves.
1
$Merck & Co (MRK.US)$ looks like he's going back to 2022
Before & after US election, I had sold out most of my stocks to reduce the risk and trim my portfolio.
Most of my stocks were closed out with profits but offset by losses in some underperforming stocks like $Centene (CNC.US)$ , $Nike (NKE.US)$ , $Merck & Co (MRK.US)$ and $Celsius Holdings (CELH.US)$ .
Both $NVIDIA (NVDA.US)$ and $Tesla (TSLA.US)$ are crucial in my portfolio for long term trading.
I had added more positions in Tesla after US election because I believe Te...
Most of my stocks were closed out with profits but offset by losses in some underperforming stocks like $Centene (CNC.US)$ , $Nike (NKE.US)$ , $Merck & Co (MRK.US)$ and $Celsius Holdings (CELH.US)$ .
Both $NVIDIA (NVDA.US)$ and $Tesla (TSLA.US)$ are crucial in my portfolio for long term trading.
I had added more positions in Tesla after US election because I believe Te...
+1
loading...
24
4
$Merck & Co (MRK.US)$ luckily i didn"t buy in on Wednesday hoo... feel relieve
This $2 Stock Remains Deeply Undervalued, Profitable in 2025, Offers 10x Upside within 20 Months
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
+18
15
1
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Morning Movers
Gapping up
$Merck & Co (MRK.US)$ shares modestly rose by 0.4% after securing a lucrative deal with LaNova Medicines, aimed at developing and marketing a new cancer treatment, potentially worth $3.3 billion.
$Disney (DIS.US)$ experienced a 9% increase in stock prices after surpassing expected fourth-quarter income and revenue, driven by strong performance in its streaming services, which significantly boosted i...
Gapping up
$Merck & Co (MRK.US)$ shares modestly rose by 0.4% after securing a lucrative deal with LaNova Medicines, aimed at developing and marketing a new cancer treatment, potentially worth $3.3 billion.
$Disney (DIS.US)$ experienced a 9% increase in stock prices after surpassing expected fourth-quarter income and revenue, driven by strong performance in its streaming services, which significantly boosted i...
35
3
$Merck & Co (MRK.US)$ in or wait eh.....
1
No comment yet
70825143 : Deal with anything related to china.